Adam Foye
6PUBLICATIONS
96CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer.Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele
|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.Lisa N Chesner, Fanny Polesso, Julie N Graff
|Jul 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression.Raunak Shrestha, Lisa N Chesner, Meng Zhang
|Jun 08, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.Arian Lundberg, Meng Zhang, Rahul Aggarwal
|Oct 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Martin Sjöström, Shuang G Zhao, Samuel Levy
|May 23, 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease.Ning Zhao, Shalini Chopra, Kai Trepka
Pageof 1
Frequent Collaborators
5 joint publications
David Quigley
4 joint publications
Rahul R Aggarwal
4 joint publications
Arian Lundberg
4 joint publications
Felix Y Feng
4 joint publications
Raunak Shrestha
4 joint publications
Martin Sjöström
3 joint publications
Thaidy Moreno-Rodriguez
3 joint publications
Joshi J Alumkal
3 joint publications
Jonathan Chou
3 joint publications
Meng Zhang
